Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer.
about
The sequential use of endocrine treatment for advanced breast cancer: where are we?Pharmacology and clinical applications of selective estrogen receptor modulators.Selective estrogen receptor modulators: tissue specificity and clinical utility.Arzoxifene: the evidence for its development in the management of breast cancer.Strength and weakness of phase I to IV trials, with an emphasis on translational aspects.Evolution of endocrine adjuvant therapy for early breast cancer.SERMs and SERMs with estrogen for postmenopausal osteoporosis.First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.
P2860
Q26997396-F2E59306-4BAB-4AE9-8B4E-2393A9A7B828Q33384192-256EE89F-55A5-496B-AC58-0027E05744B9Q34134828-51795C13-9901-425A-BB4E-E8578D7EC37BQ34449901-87CD5FB7-716A-4871-9590-24A26E89DE8AQ37039810-873D8673-20E5-47AB-87ED-2CA441EB99C4Q37725970-EE9399BE-8814-4310-A21E-7CCE256C4B90Q37743272-4EAC2D3E-3138-4AD0-8FCC-253A7FE8A553Q47884041-E6682CD4-7CB8-4B45-A6B1-B896A7B18422
P2860
Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Phase III randomized trial of ...... sitive advanced breast cancer.
@en
Phase III randomized trial of ...... sitive advanced breast cancer.
@nl
type
label
Phase III randomized trial of ...... sitive advanced breast cancer.
@en
Phase III randomized trial of ...... sitive advanced breast cancer.
@nl
prefLabel
Phase III randomized trial of ...... sitive advanced breast cancer.
@en
Phase III randomized trial of ...... sitive advanced breast cancer.
@nl
P2093
P2860
P356
P1476
Phase III randomized trial of ...... sitive advanced breast cancer.
@en
P2093
A El-Khoudary
Droloxifene 301 Study Group
K Pritchard
P2860
P2888
P304
P356
10.1023/A:1015229630260
P407
P577
2002-05-01T00:00:00Z
P6179
1024585534